New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
10:00 EDTMDVN, FUR, AEGR, RPTP, SWKS, QSII, GWAY, WGP, LLNW, CERN, STAG, IDRA, AKAMOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Akamai (AKAM) initiated with a Neutral at Macquarie... Cerner (CERN) initiated with an Overweight at JPMorgan... Greenway Medical (GWAY) initiated with an Overweight at JPMorgan... Idera Pharmaceuticals (IDRA) initiated with an Overweight at Piper Jaffray... Limelight Networks (LLNW) initiated with a Neutral at Macquarie... Quality Systems (QSII) initiated with an Underweight at JPMorgan... STAG Industrial (STAG) initiated with a Market Perform at Wells Fargo... Western Gas Equity (WGP) initiated with a Buy at Citigroup... Winthrop Realty (FUR) initiated with a Market Perform at JMP Securities... Skyworks (SWKS) initiated with a Buy at Longbow... Aegerion (AEGR) initiated with a Buy at Janney Capital... Medivation (MDVN) initiated with a Buy at Janney Capital... Raptor Pharmaceuticals (RPTP) initiated with a Buy at Janney Capital.
News For AKAM;CERN;GWAY;IDRA;LLNW;QSII;STAG;WGP;FUR;SWKS;AEGR;MDVN;RPTP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 31, 2015
09:07 EDTSWKSB. Riley to hold a tour
Silicon Valley Tech Tour travels throughout the Silicon Valley visiting various local tech companies on August 31-September 3.
07:01 EDTAKAMAkamai a pure play on over-the-top TV theme, says Deutsche Bank
Deutsche Bank analyst Vijay Bhagavath recommends Akamai as a pure play on the TV over-the-top theme. He views Internet video traffic from OTT as a $500M-plus a year opportunity for the company and raised his price target for shares to $80 from $77. He thinks Akamai's Media Delivery business can grow high teens versus the consensus view of mid-teens and keeps a Buy rating on the name.
August 28, 2015
10:02 EDTAKAMOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ADP (ADP) upgraded to Outperform from Market Perform at William Blair... ASML (ASML) upgraded to Buy from Hold at Berenberg... Abercrombie & Fitch (ANF) upgraded on Hollister fundamentals at RBC Capital... Akamai (AKAM) upgraded to Outperform from Market Perform at JMP Securities... Ares Capital (ARCC) upgraded to Outperform from Market Perform at Raymond James... Banco Santander (SAN) upgraded on valuation at Deutsche Bank... CIBC (CM) upgraded to Neutral from Underperform at Credit Suisse... Canon (CAJ) upgraded to Hold from Sell at Deutsche Bank... Citi (C) upgraded to Buy from Neutral at Guggenheim... Ctrip.com (CTRP) upgraded to Buy from Hold at Stifel... El Pollo Loco (LOCO) upgraded at Stifel... Genomic Health (GHDX) upgraded to Market Perform from Underperform at Raymond James... Golar LNG (GLNG) upgraded on valuation, upcoming project completion at Stifel... Habit Restaurants (HABT) upgraded to Buy from Hold at Stifel... Helmerich & Payne (HP) upgraded to Overweight from Equal Weight at Stephens... Himax (HIMX) upgraded to Outperform from Neutral at Credit Suisse... Huntington Bancshares (HBAN) upgraded to Buy from Neutral at Guggenheim... InterContinental (IHG) upgraded to Outperform from Neutral at Credit Suisse... Knight Transportation (KNX) upgraded to Strong Buy on valuation at Raymond James... LogMeln (LOGM) upgraded to Overweight from Sector Weight at Pacific Crest... Patterson Companies (PDCO) upgraded to Overweight from Neutral at Piper Jaffray... Qunar (QUNR) upgraded on valuation, positive catalysts at Stifel... Regions Financial (RF) upgraded to Buy from Neutral at Guggenheim... Ryder (R) upgraded to Strong Buy from Outperform at Raymond James... SVB Financial (SIVB) upgraded to Buy from Neutral at DA Davidson... Seagate (STX) upgraded to Buy from Hold at Cross Research... Sinopec (SNP) upgraded to Neutral from Sell at Citi... Summit Hotel Properties (INN) upgraded to Outperform at Baird... Texas Capital (TCBI) upgraded to Buy from Neutral at DA Davidson... The Medicines Co. (MDCO) upgraded to Buy from Hold at Jefferies... U.S. Bancorp (USB) upgraded to Buy from Neutral at Guggenheim... Weatherford (WFT) upgraded to Overweight from Equal Weight at Stephens.
09:25 EDTAKAMAkamai upgraded on catalysts, valuation at JMP Securities
Subscribe for More Information
07:12 EDTMDVNWilliam Blair names 21 stocks best positioned for volatile markets
Subscribe for More Information
06:22 EDTAKAMAkamai upgraded to Outperform from Market Perform at JMP Securities
Subscribe for More Information
August 27, 2015
08:35 EDTMDVNMedivation price target raised to $166 at William Blair after talazoparib deal
Subscribe for More Information
August 26, 2015
07:09 EDTIDRAVertex, Novavax among select biotechs to buy on weakness, says Piper Jaffray
Subscribe for More Information
07:01 EDTLLNWLimelight Networks selected by eDreams Odigeo for Orchestrate Delivery service
Subscribe for More Information
August 25, 2015
09:26 EDTCERNHospira, Cerner expand IV-EMR integration agreement
Subscribe for More Information
August 24, 2015
18:02 EDTSWKSS&P 500 enters correction territory amid global growth concerns
Subscribe for More Information
16:07 EDTSTAGSTAG Industrial signs 134,400 square foot lease in Gresham, OR
Subscribe for More Information
08:14 EDTAKAMAkamai management to meet with Oppenheimer
Subscribe for More Information
07:42 EDTCERNCerner should be bought with valuation at multi-year low, says Piper Jaffray
Subscribe for More Information
07:02 EDTMDVNMedivation to acquire worldwide rights to Talazoparib from BioMarin
Medivation (MDVN) and BioMarin Pharmaceutical (BMRN) have entered into an asset purchase agreement under which Medivation will acquire all worldwide rights to talazoparib, a highly-potent, orally-available poly ADP ribose polymerase inhibitor currently in a Phase 3 study for the treatment of patients with deleterious germline BRCA 1 or BRCA 2 mutations and locally advanced and/or metastatic breast cancer. Under the agreement, Medivation will be responsible for all research, development, regulatory and commercialization activities for all indications on a global basis. Under the terms of the agreement, Medivation will pay BioMarin $410 million upfront, up to an additional $160 million upon the achievement of regulatory and sales-based milestones and mid-single digit royalties for talazoparib. At the closing of the transaction, Medivation will assume all financial obligations associated with the development and commercialization of talazoparib. The closing of the transaction is conditioned on the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The transaction is anticipated to close in 2015.
August 20, 2015
17:19 EDTRPTPRaptor Pharmaceuticals' expanded label for Procysbi approved by FDA
Subscribe for More Information
09:24 EDTCERNCerner, CoverMyMeds integrate to streamline electronic prior authorization
Subscribe for More Information
07:34 EDTAKAMAkamai resumed with an Overweight at Pacific Crest
Subscribe for More Information
August 19, 2015
16:08 EDTCERNLeidos awarded $4.3B DoD contract
Leidos (LDOS) was awarded a prime contract by the Department of Defense, or DoD, to provide an off-the-shelf electronic health record solution, integration activities and deployment across the Military Health System. The contract, known as the Defense Healthcare Management System Modernization, or DHMSM, program, is an initiative designed to modernize the military's healthcare system in a meaningful way, enabling patients and clinicians to capture and share health data that can improve the continuity and quality of care for 9.6M active military, their families, and their beneficiaries. As the prime contractor, Leidos established a team of proven innovators and industry leaders to form the Leidos Partnership for Defense Health. Cerner (CERN), Accenture Federal Services (ACN) and Henry Schein (HSIC) form the core team, complemented with a broad range of large and small business teammates, vendors and suppliers who bring proven experience and expertise specific to both the commercial and DoD healthcare markets.
05:50 EDTSWKSStocks with implied volatility movement; SWKS CNX
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use